GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cann Group Ltd (OTCPK:CNGGF) » Definitions » Cash, Cash Equivalents, Marketable Securities

CNGGF (Cann Group) Cash, Cash Equivalents, Marketable Securities : $0.04 Mil (As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Cann Group Cash, Cash Equivalents, Marketable Securities?

Cann Group's quarterly cash, cash equivalents, marketable securities declined from Dec. 2023 ($1.10 Mil) to Jun. 2024 ($1.09 Mil) but then stayed the same from Jun. 2024 ($1.09 Mil) to Dec. 2024 ($0.04 Mil).

Cann Group's annual cash, cash equivalents, marketable securities declined from Jun. 2022 ($1.35 Mil) to Jun. 2023 ($0.51 Mil) but then increased from Jun. 2023 ($0.51 Mil) to Jun. 2024 ($1.09 Mil).


Cann Group Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Cann Group's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cann Group Cash, Cash Equivalents, Marketable Securities Chart

Cann Group Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Cash, Cash Equivalents, Marketable Securities
Get a 7-Day Free Trial 1.07 2.37 1.35 0.51 1.09

Cann Group Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.85 0.51 1.10 1.09 0.04

Cann Group Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Cann Group  (OTCPK:CNGGF) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Cann Group Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Cann Group's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Cann Group Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cann Group Ltd (OTCPK:CNGGF) » Definitions » Cash, Cash Equivalents, Marketable Securities
Traded in Other Exchanges
Address
262-276 Lorimer Street, Ground Floor, Port Melbourne, VIC, AUS, 3207
Cann Group Ltd is engaged in the cultivation of medicinal cannabis for both medicinal and research purposes under the licenses and permits issued to the company, the development and manufacture (via third-party arrangements) of finished product formulations. Geographically, the company operates in Europe and Australia. The company derives maximum revenue from Australia.

Cann Group Headlines

From GuruFocus

Cann Group Ltd Annual Shareholders Meeting Transcript

By GuruFocus Research 02-13-2024

Cann Group Ltd at Investor Update webinar Transcript

By GuruFocus Research 02-13-2024

Full Year 2019 Cann Group Ltd Earnings Call Transcript

By GuruFocus Research 02-13-2024

Half Year 2021 Cann Group Ltd Earnings Call Transcript

By GuruFocus Research 02-13-2024

Cann Group Ltd Ordinary Shareholders Meeting Transcript

By GuruFocus Research 02-13-2024

Cann Group Ltd Corporate Call Transcript

By GuruFocus Research 02-13-2024

Cann Group Ltd Annual Shareholders Meeting Transcript

By GuruFocus Research 02-13-2024

Half Year 2023 Cann Group Ltd Earnings Call Transcript

By GuruFocus Research 02-13-2024